Literature DB >> 11371131

Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.

R Rouzier1, P Morice, C Haie-Meder, C Lhomme, M F Avril, P Duvillard, D Castaigne.   

Abstract

OBJECTIVE: Epithelial disorders are found adjacent to vulvar carcinoma in 70-80% of patients. Epithelial disorder may be human papillomavirus related [undifferentiated high-grade vulvar intraepithelial neoplasia (VIN III)] or not [vulvar lichen sclerosus and squamous cell hyperplasia with or without atypia (differentiated VIN III)]. The aim of this study was to evaluate the impact of associated epithelial disorders on the outcome of patients with cancer of the vulva.
METHODS: A retrospective study about 108 patients treated for a squamous cell carcinoma of the vulva was performed. Clinical, surgical, histopathologic, and follow-up data were collected and analyzed.
RESULTS: Seventy-seven patients had an epithelial alteration adjacent to the invasive squamous carcinoma. Squamous cell hyperplasia and lichen sclerosus were identified in 48% (n = 52) and undifferentiated VIN III in 23% (n = 25). The 5-year disease-free and overall survival rates were 39 and 55%, respectively. In univariate analysis, age <70, a tumor size <2 cm, depth of invasion < or =1 mm, tumor thickness < or =5 mm, negative lymph node pathology, lymph node resection, and undifferentiated VIN III were predictive of survival. Using Cox's proportional hazards method, undifferentiated VIN III (P = 0.02), depth of invasion < or =1 mm (P < 0.01), and a pathological negative node status (P < 0.01) were independent predictors of survival. Patients without associated epithelial alterations had clinical and prognostic features comparable to those of patients with vulvar lichen sclerosus and squamous cell hyperplasia.
CONCLUSION: The results of this study support the view that histological evidence of epithelial alterations adjacent to invasive carcinoma can serve to separate patients that differ in terms of prognosis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11371131     DOI: 10.1006/gyno.2001.6198

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology.

Authors:  M van Seters; F J W ten Kate; M van Beurden; R H M Verheijen; C J L M Meijer; M P M Burger; T J M Helmerhorst
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

2.  Do Langerhans cells play a role in vulvar epithelium resistance to squamous cell carcinoma?

Authors:  Helena Rotsztejn; Ewa Trznadel-Budźko; Dorota Jesionek-Kupnicka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-20       Impact factor: 4.291

3.  Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities.

Authors:  R P de Bie; H P van de Nieuwenhof; R L M Bekkers; W J G Melchers; A G Siebers; J Bulten; L F A G Massuger; J A de Hullu
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

4.  Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva.

Authors:  Sara Iacoponi; Ignacio Zapardiel; Maria Dolores Diestro; Alicia Hernandez; Javier De Santiago
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

5.  Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer.

Authors:  Yohann Dabi; Marie Gosset; Sylvie Bastuji-Garin; Rana Mitri-Frangieh; Sofiane Bendifallah; Emile Darai; Bernard Jean Paniel; Roman Rouzier; Bassam Haddad; Cyril Touboul
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.